Several companies receive funding this week across Enterprise Applications, Employment Innovation, IT Outsourcing, BPO Services and Cybersecurity.
Tag: tracxn
Key Insights into the UK FinTech Ecosystem and Funding Trends in Q3 2024
The UK fintech ecosystem secured $533 million in funding during Q3 2024, marking a significant 72% decline from the previous quarter's $1.9 billion.
US FinTech Startups See 53% Decline In Funding in H1 2024, But Q2 Surge Offers Optimis
Investment Tech, Payments, and Finance & Accounting Tech were the top-performing segments in H1 2024.
US Tech Startups See 19% Decline in Funding in H1 2024, Despite Rise in Early-Stage Investments
Tracxn has published its Geo Semi-Annual Report: US Tech H1 2024, revealing that the US led global startup funding with $54.8 billion raised, despite a 19% decrease from $68 billion in H1 2023.
Funding Into US Tech Startups Drops 38% During Q3 2024
The number of acquisitions fell to 243 in this quarter from 354 during the previous quarter of this year and 344 in the corresponding quarter in 2023.
Tracxn Deals Of The Week For August 2: Knime, Yida, Groq, Datch and More
Tracxn tracks Innovative companies across over 300 technology sectors and more than 1000 emerging themes worldwide, plus dedicated geographic coverage on over 30 countries.
Tracxn Deals Rundown: AI, Cybersecurity, and Big Data (May 24-30, 2024)
FintechOS, a provider of AI-based software suite for the banking and insurance industry, raised $60 million from BlackRock and others.
Tracxn Deals Rundown: AI, Cybersecurity, and Big Data Analytics (May 3-9, 2024)
Wayve, a provider of AI- and cloud-enabled software for autonomous cars, raised $1.05 billion round from SoftBank Group, Microsoft, and NVIDIA.
Tracxn Deals Rundown: AI and Cybersecurity (April 26-May 2, 2024)
Blaize, a provider of edge AI infrastructure solutions, raised a $106M round from Temasek, Franklin Templeton Investments, Mercedes-Benz, and others.
Tracxn Deals Rundown: AI and Cybersecurity (April 19-25, 2024)
Xaira, an AI-enabled platform for drug discovery development, raised a $1B round from Arch Venture Partners, Foresite Labs, and more.